Volume 23, Issue 6 pp. 1404-1413
ORIGINAL ARTICLE

Oncological outcomes after complete mesocolic excision in right-sided colon cancer: a population-based study

Richard Bernhoff

Corresponding Author

Richard Bernhoff

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Department of Surgery, Capio St Göran Hospital, Stockholm, Sweden

Correspondence

Dr Richard Bernhoff, Department of Surgery, Capio St Göran Hospital, Stockholm 11281, Sweden.

Email: [email protected]

Search for more papers by this author
Annika Sjövall

Annika Sjövall

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Division of Coloproctology, A5:01, Karolinska University Hospital, Stockholm, Sweden

Search for more papers by this author
Fredrik Granath

Fredrik Granath

Department of Medicine, Karolinska Institutet, Stockholm, Sweden

Search for more papers by this author
Torbjörn Holm

Torbjörn Holm

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Department of Surgery, Södersjukhuset, Stockholm, Sweden

Search for more papers by this author
Anna Martling

Anna Martling

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Division of Coloproctology, A5:01, Karolinska University Hospital, Stockholm, Sweden

Search for more papers by this author
Christian Buchli

Christian Buchli

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

Division of Coloproctology, A5:01, Karolinska University Hospital, Stockholm, Sweden

Search for more papers by this author
First published: 23 February 2021
Citations: 12

Funding information

Financial support was provided through the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institute, and by the Stockholm Cancer Society. The MDT workshops at the Karolinska University Hospital were financed and supported by Medtronic Minimally Invasive Therapies (formerly Covidien).

Abstract

Aim

Complete mesocolic excision (CME) has been proposed as the preferred surgical technique for resection of colon cancer. This prospective cohort study evaluates the effect of CME surgery on colon cancer mortality after right-sided hemicolectomy on a population level.

Methods

Data from the Swedish Colorectal Cancer Registry and the Cause of Death Registry on all patients treated with elective right-sided hemicolectomy for colon cancer Stages I–III in the Stockholm County 2008–2012 were analysed. Adherence to principles of CME surgery was determined by structured analysis of anonymized surgical reports regarding the presence of five essential features. The exposure to CME was graded as group 0 (not exposed to CME), group 1 (intermediate) and group 2 (exposed to CME).

Results

In total, 1171 patients were analysed with 234 (20.0%) patients in CME group 0, 453 (38.7%) patients in CME group 1 and 484 (41.3%) in CME group 2. The 5-year colon cancer mortality was 20.2% in CME group 0, 13.9% in CME group 1 and 13.1% in CME group 2 (P = 0.026). The adjusted hazard ratio for colon cancer mortality was 0.61 (95% CI 0.42–0.91; P = 0.014) for CME group 1 and 0.52 (95% CI 0.35–0.77; P = 0.001) for CME group 2.

Discussion

The presence of predefined CME features in surgical reports was related to a graded benefit on cancer-specific mortality after right-sided hemicolectomy for colon cancer Stages I–III.

CONFLICT OF INTERESTS

None.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.